226 related articles for article (PubMed ID: 24488412)
21. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial.
Saunders P; Tsipouri V; Keir GJ; Ashby D; Flather MD; Parfrey H; Babalis D; Renzoni EA; Denton CP; Wells AU; Maher TM
Trials; 2017 Jun; 18(1):275. PubMed ID: 28619061
[TBL] [Abstract][Full Text] [Related]
22. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
de Lauretis A; Veeraraghavan S; Renzoni E
Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
[TBL] [Abstract][Full Text] [Related]
23. Significance of connective tissue diseases features in pulmonary fibrosis.
Cottin V
Eur Respir Rev; 2013 Sep; 22(129):273-80. PubMed ID: 23997055
[TBL] [Abstract][Full Text] [Related]
24. Developing disease activity and response criteria in connective tissue disease-related interstitial lung disease.
Saketkoo LA; Matteson EL; Brown KK; Seibold JR; Strand V;
J Rheumatol; 2011 Jul; 38(7):1514-8. PubMed ID: 21724725
[TBL] [Abstract][Full Text] [Related]
25. [Interstitial Lung Disease associated with Connective Tissue Diseases].
Sarbu A; Guler SA
Ther Umsch; 2024 Feb; 81(1):4-11. PubMed ID: 38655827
[TBL] [Abstract][Full Text] [Related]
26. Serum IL-36 cytokines levels in idiopathic pulmonary fibrosis and connective tissue disease-associated interstitial lung diseases.
Zhang Q; Guo L; Song X; Lv C; Tang P; Li Y; Ding Q; Li M
Clin Chim Acta; 2022 May; 530():8-12. PubMed ID: 35219714
[TBL] [Abstract][Full Text] [Related]
27. Serum Rcn3 level is a potential diagnostic biomarker for connective tissue disease-associated interstitial lung disease and reflects the severity of pulmonary function.
Ding F; Yang L; Wang Y; Wang J; Ma Y; Jin J
BMC Pulm Med; 2023 Feb; 23(1):68. PubMed ID: 36800954
[TBL] [Abstract][Full Text] [Related]
28. CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis.
Chung JH; Cox CW; Montner SM; Adegunsoye A; Oldham JM; Husain AN; Vij R; Noth I; Lynch DA; Strek ME
AJR Am J Roentgenol; 2018 Feb; 210(2):307-313. PubMed ID: 29140119
[TBL] [Abstract][Full Text] [Related]
29. [2018 Chinese expert-based consensus statement regarding the diagnosis and treatment of interstitial lung disease associated with connective tissue diseases].
;
Zhonghua Nei Ke Za Zhi; 2018 Aug; 57(8):558-565. PubMed ID: 30060326
[TBL] [Abstract][Full Text] [Related]
30. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.
Oguz EO; Kucuksahin O; Turgay M; Yildizgoren MT; Ates A; Demir N; Kumbasar OO; Kinikli G; Duzgun N
Clin Rheumatol; 2016 Mar; 35(3):663-6. PubMed ID: 26758437
[TBL] [Abstract][Full Text] [Related]
31. Serum KL-6 level as a biomarker of interstitial lung disease in childhood connective tissue diseases: a pilot study.
Kilinc AA; Arslan A; Yildiz M; Kucur M; Adrovic A; Barut K; Sahin S; Cokugras H; Kasapcopur O
Rheumatol Int; 2020 Oct; 40(10):1701-1706. PubMed ID: 31784789
[TBL] [Abstract][Full Text] [Related]
32. [Interstitial lung disease associated with connective tissue diseases: diagnosis and treatment approaches].
Kar Kurt Ö; Pamuk ÖN; Kurt B
Tuberk Toraks; 2012; 60(4):393-400. PubMed ID: 23289473
[TBL] [Abstract][Full Text] [Related]
33. Lung Cancer development and mortality in interstitial lung disease with and without connective tissue diseases: a five-year Nationwide population-based study.
Choi WI; Lee DY; Choi HG; Lee CW
Respir Res; 2019 Jun; 20(1):117. PubMed ID: 31182103
[TBL] [Abstract][Full Text] [Related]
34. Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review.
Atzeni F; Gerardi MC; Barilaro G; Masala IF; Benucci M; Sarzi-Puttini P
Expert Rev Clin Immunol; 2018 Jan; 14(1):69-82. PubMed ID: 29202589
[TBL] [Abstract][Full Text] [Related]
35. Interstitial Lung Disease in Connective Tissue Disease: A Common Lesion With Heterogeneous Mechanisms and Treatment Considerations.
Shao T; Shi X; Yang S; Zhang W; Li X; Shu J; Alqalyoobi S; Zeki AA; Leung PS; Shuai Z
Front Immunol; 2021; 12():684699. PubMed ID: 34163483
[TBL] [Abstract][Full Text] [Related]
36. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
[TBL] [Abstract][Full Text] [Related]
37. Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD).
Jee AS; Corte TJ
Drugs; 2019 Sep; 79(14):1511-1528. PubMed ID: 31399860
[TBL] [Abstract][Full Text] [Related]
38. Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand?
Elhai M; Avouac J; Allanore Y
Semin Arthritis Rheum; 2020 Jun; 50(3):480-491. PubMed ID: 32089354
[TBL] [Abstract][Full Text] [Related]
39. Interstitial lung disease in connective tissue disease--mechanisms and management.
Wells AU; Denton CP
Nat Rev Rheumatol; 2014 Dec; 10(12):728-39. PubMed ID: 25266451
[TBL] [Abstract][Full Text] [Related]
40. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.
Enomoto N; Oyama Y; Enomoto Y; Yasui H; Karayama M; Kono M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Chron Respir Dis; 2019; 16():1479972318809476. PubMed ID: 30380910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
